Next Article in Journal
Targeted Molecular Imaging Using Aptamers in Cancer
Previous Article in Journal
In Silico SAR Studies of HIV-1 Inhibitors
Previous Article in Special Issue
Design, Synthesis, In Vitro, and Initial In Vivo Evaluation of Heterobivalent Peptidic Ligands Targeting Both NPY(Y1)- and GRP-Receptors—An Improvement for Breast Cancer Imaging?
Article Menu

Export Article

Open AccessArticle
Pharmaceuticals 2018, 11(3), 70; https://doi.org/10.3390/ph11030070

Design and Synthesis of 99mTcN-Labeled Dextran-Mannose Derivatives for Sentinel Lymph Node Detection

1
Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara 44121, Italy
2
Department of Physic and Earth Science, University of Ferrara, Ferrara 44122, Italy
3
Department of Chemical and Pharmaceutical Sciences, University of Ferrara, Ferrara 44121, Italy
*
Author to whom correspondence should be addressed.
Received: 15 June 2018 / Revised: 11 July 2018 / Accepted: 12 July 2018 / Published: 16 July 2018
View Full-Text   |   Download PDF [3175 KB, uploaded 16 July 2018]   |  

Abstract

Background: New approaches based on the receptor-targeted molecular interaction have been recently developed with the aim to investigate specific probes for sentinel lymph nodes. In particular, the mannose receptors expressed by lymph node macrophages became an attractive target and different multifunctional mannose derivate ligands for the labeling with 99mTc have been developed. In this study, we report the synthesis of a specific class of dextran-based, macromolecular, multifunctional ligands specially designed for labeling with the highly stable [99mTc≡N]2+ core. Methods: The ligands have been obtained by appending to a macromolecular dextran scaffold pendant arms bearing a chelating moiety for the metallic group and a mannosyl residue for allowing the interaction of the resulting macromolecular 99mTc conjugate with specific receptors on the external membrane of macrophages. Two different chelating systems have been selected, S-methyl dithiocarbazate [H2N‒NH‒C(=S)SCH3=HDTCZ] and a sequence of two cysteine residues, that in combination with a monophosphine coligand, are able to bind the [99mTc≡N]2+ core. Conclusions: High-specific-activity labeling has been obtained by simple mixing and heating of the [99mTc≡N]2+ group with the new mannose-dextran derivatives. View Full-Text
Keywords: sentinel lymph node; dextran; mannose; 99mTc-radiopharmaceuticals sentinel lymph node; dextran; mannose; 99mTc-radiopharmaceuticals
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Boschi, A.; Pasquali, M.; Trapella, C.; Massi, A.; Martini, P.; Duatti, A.; Guerrini, R.; Zanirato, V.; Fantinati, A.; Marzola, E.; Giganti, M.; Uccelli, L. Design and Synthesis of 99mTcN-Labeled Dextran-Mannose Derivatives for Sentinel Lymph Node Detection. Pharmaceuticals 2018, 11, 70.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top